BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Meijer LL, Alberga AJ, de Bakker JK, van der Vliet HJ, Le Large TYS, van Grieken NCT, de Vries R, Daams F, Zonderhuis BM, Kazemier G. Outcomes and Treatment Options for Duodenal Adenocarcinoma: A Systematic Review and Meta-Analysis. Ann Surg Oncol. 2018;25:2681-2692. [PMID: 29946997 DOI: 10.1245/s10434-018-6567-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Nitta N, Ohgi K, Sugiura T, Okamura Y, Ito T, Yamamoto Y, Ashida R, Sasaki K, Uesaka K. Prognostic Impact of Pancreatic Invasion in Duodenal Carcinoma: A Single-Center Experience. Ann Surg Oncol 2020;27:4553-60. [PMID: 32367502 DOI: 10.1245/s10434-020-08512-8] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Platoff RM, Kellish AS, Hakim A, Gaughan JP, Atabek UM, Spitz FR, Hong YK. Simple Versus Radical Resection for Duodenal Adenocarcinoma: A Propensity Score Matched Analysis of National Cancer Database. Am Surg 2021;87:266-75. [PMID: 32927979 DOI: 10.1177/0003134820951432] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Khosla D, Dey T, Madan R, Gupta R, Goyal S, Kumar N, Kapoor R. Small bowel adenocarcinoma: An overview. World J Gastrointest Oncol 2022; 14(2): 413-422 [DOI: 10.4251/wjgo.v14.i2.413] [Reference Citation Analysis]
4 Wang W, Liu Q, Zhao ZM, Tan XL, Wang ZZ, Zhang KD, Liu R. Comparison of robotic and open pancreaticoduodenectomy for primary nonampullary duodenal adenocarcinoma: a retrospective cohort study. Langenbecks Arch Surg 2021. [PMID: 34471952 DOI: 10.1007/s00423-021-02303-9] [Reference Citation Analysis]
5 Zhang G, Lin L, Dong D, Qiu H, Liu T, Lian L, Shen G. Nivolumab plus regorafenib in patients with small bowel adenocarcinoma: A case report. Medicine (Baltimore) 2021;100:e24295. [PMID: 33530218 DOI: 10.1097/MD.0000000000024295] [Reference Citation Analysis]
6 Meijer LL, Kazemier G. ASO Author Reflections: Current Treatment Options for Duodenal Adenocarcinoma-A Call for Collaborative Studies. Ann Surg Oncol. 2018;25:737-738. [PMID: 30327972 DOI: 10.1245/s10434-018-6896-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Linden K, Melillo A, Gaughan J, Obinero C, Kellish A, Wozniak MR, Patel RM, Pandya V, Atabek U, Spitz F, Hong YK. The Role of Neoadjuvant Versus Adjuvant Therapy for Duodenal Adenocarcinoma: A National Cancer Database Propensity Score Matched Analysis. Am Surg 2021;87:1066-73. [PMID: 33291951 DOI: 10.1177/0003134820954821] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Bracale U, Pontecorvi E, Silvestri V, Cuccurullo D, D'Ambra M, Lionetti R, Coppola A, Carannante F, Pirozzi F, Peltrini R, Sciuto A, Corcione F. Laparoscopic segmental resection for tumours of the Angle of Treitz: a challenging but feasible surgical option. Results from a retrospective case-series analysis. Updates Surg 2021;73:179-86. [PMID: 33146889 DOI: 10.1007/s13304-020-00910-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Fields AC, Lu PW, Li GZ, Welten V, Jolissaint JS, Vierra BM, Saadat LV, Larson AC, Atkinson RB, Melnitchouk N. Current practices and future steps for hyperthermic intraperitoneal chemotherapy. Curr Probl Surg 2020;57:100727. [PMID: 32151327 DOI: 10.1016/j.cpsurg.2019.100727] [Reference Citation Analysis]
10 Jensen KK, Storkholm JH, Chen I, Burgdorf SK, Hansen CP. Long-term results after resection of primary duodenal adenocarcinoma: A retrospective cohort study. International Journal of Surgery 2022. [DOI: 10.1016/j.ijsu.2022.106599] [Reference Citation Analysis]
11 Hanan S, Luvsannyam E, Jain MS, Laller S, Cheema T, Mellon C, Teed D, Somagutta M, Ahmad LN, Tiesenga FM. A Rare Case of Three Distinct Gastrointestinal Neoplasms Occurring Simultaneously in an Elderly Patient. J Med Cases 2021;12:419-23. [PMID: 34691340 DOI: 10.14740/jmc3765] [Reference Citation Analysis]
12 de Jong EJM, van der Geest LG, Besselink MG, Bouwense SAW, Buijsen J, Dejong CHC, Koerkamp BG, Heij LR, de Hingh IHJT, Hoge C, Kazemier G, van Laarhoven HWM, de Meijer VE, Stommel MWJ, Tjan-Heijnen VCG, Valkenburg-van Iersel LBJ, Wilmink JW, Geurts SME, de Vos-Geelen J; Dutch Pancreatic Cancer Group. Treatment and overall survival of four types of non-metastatic periampullary cancer: nationwide population-based cohort study. HPB (Oxford) 2022:S1365-182X(22)00044-2. [PMID: 35135724 DOI: 10.1016/j.hpb.2022.01.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Matsuura H, Saito A, Amano Y, Morishima K, Sasanuma H, Lefor AK, Sata N. Intussusception of the third portion of the duodenum secondary to a primary duodenal malignancy: A case report. International Journal of Surgery Case Reports 2022;94:107085. [DOI: 10.1016/j.ijscr.2022.107085] [Reference Citation Analysis]
14 de Jong EJM, Mommers I, Fariña Sarasqueta A, van der Geest LG, Heij L, de Hingh IHJT, Homs MYV, Tjan-Heijnen VCG, Valkenburg-van Iersel LBJ, Wilmink JW, Geurts SME, de Vos-Geelen J; Dutch Pancreatic Cancer Group. Adjuvant and first-line palliative chemotherapy regimens in patients diagnosed with periampullary cancer: a short report from a nationwide registry. Acta Oncol 2022;61:591-6. [PMID: 35382678 DOI: 10.1080/0284186X.2022.2053199] [Reference Citation Analysis]
15 Lee TC, Wima K, Morris MC, Winer LK, Sussman JJ, Ahmad SA, Wilson GC, Patel SH. Small Bowel Adenocarcinomas: Impact of Location on Survival. J Surg Res 2020;252:116-24. [PMID: 32278965 DOI: 10.1016/j.jss.2020.03.017] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Dave A, Wiseman JT, Cloyd JM. Duodenal adenocarcinoma: neoadjuvant and adjuvant therapy strategies. Expert Opinion on Orphan Drugs 2019;7:463-72. [DOI: 10.1080/21678707.2019.1684257] [Reference Citation Analysis]
17 Burasakarn P, Higuchi R, Nunobe S, Kanaji S, Eguchi H, Okada KI, Fujii T, Nagakawa Y, Kanetaka K, Yamashita H, Yamada S, Kuroda S, Aoyama T, Akahori T, Nakagawa K, Yamamoto M, Yamaue H, Sho M, Kodera Y; Japan Duodenal Cancer Guideline Committee. Limited resection vs. pancreaticoduodenectomy for primary duodenal adenocarcinoma: a systematic review and meta-analysis. Int J Clin Oncol 2021;26:450-60. [PMID: 33386555 DOI: 10.1007/s10147-020-01840-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
18 Yasuda S, Harada S, Tsujimoto A, Aoki S, Takei T, Migita K, Ueno M, Tatsumi M, Watanabe A. A pathological complete response by chemotherapy with S-1 and oxaliplatin for a locally advanced duodenal adenocarcinoma in Lynch syndrome: a case report. Surg Case Rep 2019;5:146. [PMID: 31637551 DOI: 10.1186/s40792-019-0712-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Wang Z, Li W, Wei Y, An L, Su S, Xi C, Wang K, Hong D, Shi Y. A HER2-mutant patient with late-stage duodenal adenocarcinoma benefited from anti-HER2 therapy and PD-1 inhibition: a case report. J Gastrointest Oncol 2021;12:1939-43. [PMID: 34532140 DOI: 10.21037/jgo-21-311] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Meijer LL, Strijker M, de Bakker JK, Toennaer JG, Zonderhuis BM, van der Vliet HJ, Wilmink H, Verheij J, Daams F, Busch OR, van Grieken NC, Besselink MG, Kazemier G. Clinical outcomes of patients with duodenal adenocarcinoma and intestinal-type papilla of Vater adenocarcinoma. World J Gastrointest Oncol 2020; 12(3): 347-357 [PMID: 32206184 DOI: 10.4251/wjgo.v12.i3.347] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Huang H, Sun J, Li Z, Zang L, Zhu H, Zhang X, Yu X, Pandurangan A. Clinical Analysis of C-Shaped Embedded Pancreaticojejunostomy in Pancreaticoduodenectomy. Journal of Oncology 2022;2022:1-9. [DOI: 10.1155/2022/7427146] [Reference Citation Analysis]
22 Yang QY, Tang CT, Huang YF, Shao DT, Shu X. Development and validation of a nomogram for primary duodenal carcinoma: a multicenter, population-based study. Future Oncol 2022. [PMID: 35114801 DOI: 10.2217/fon-2021-0622] [Reference Citation Analysis]
23 Kaslow SR, Prendergast K, Vitiello GA, Hani L, Berman RS, Lee AY, Correa-gallego C. Systemic therapy for duodenal adenocarcinoma: An analysis of the National Cancer Database (NCDB). Surgery 2022. [DOI: 10.1016/j.surg.2022.03.009] [Reference Citation Analysis]
24 Shiba S, Miki A, Ohzawa H, Teratani T, Sakuma Y, Lefor AK, Kitayama J, Sata N. Functional Expression of Mucin1 in Human Duodenal Adenocarcinoma. Journal of Surgical Research 2019;238:79-89. [DOI: 10.1016/j.jss.2019.01.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]